Popular ’war on drugs’ rhetoric postulates drug use in the West as the product of the drug production and trafficking roles of non-western societies and non-western peoples within and outside the West. In such rhetoric, African societies and people of African descent in Africa and in Diaspora have received criticisms for their respective roles in drug production and drug trafficking, including the position of many African countries as transit routes for drugs exported to the West. By contrast, the abuse of drugs by populations of African origin around the globe and the harmful consequences of the drug trade and drug abuse on these populations has been little studied. Drawing on contributions from seven countries in Africa; two countries in Europe; and seven countries in the Americas, this volume examines the relationships between drug use, drug trafficking, drug controls and the black population of a given society. Each chapter examines the nature and pattern of drug use or abuse; the effects of drug use or abuse (illegal or/and legal) on other areas such as health and crime; the nature, pattern, and perpetration of trafficking and sale of illegal or/and legal drugs; and past and current policies and control of illegal and /or legal drugs. It will be essential reading for all students, academics and policy-makers working in the area of drug control.

Drawing on contributions from seven countries in Africa; two countries in Europe; and seven countries in the Americas, this volume examines the relationships between drug use, drug trafficking, drug controls and the black population of a given society. Each chapter examines the nature and pattern of drug use or abuse; the effects of drug use or abuse (illegal or/and legal) on other areas such as health and crime; the nature, pattern, and perpetration of trafficking and sale of illegal or/and legal drugs; and past and current policies and control of illegal and /or legal drugs. It will be essential reading for all students, academics and policy-makers working in the area of drug control.

This cutting-edge volume is the first to address the burgeoning interest in drugs and Africa among scholars, policymakers, and the general public. It brings together an interdisciplinary group of leading academics and practitioners to explore the use, trade, production, and control of mind-altering substances on the continent

The 2019 World Drug Report will include an updated overview of recent trends on production, trafficking and consumption of key illicit drugs. The Report contains a global overview of the baseline data and estimates on drug demand and supply and provides the reference point for information on the drug situation worldwide.

Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.

After arriving from South Asia approximately a thousand years ago, cannabis quickly spread throughout the African continent. European accounts of cannabis in Africa—often fictionalized and reliant upon racial stereotypes—shaped widespread myths about the plant and were used to depict the continent as a cultural backwater and Africans as predisposed to drug use. These myths continue to influence contemporary thinking about cannabis. In The African Roots of Marijuana, Chris S. Duvall corrects common misconceptions while providing an authoritative history of cannabis as it flowed into, throughout, and out of Africa. Duvall shows how preexisting smoking cultures in Africa transformed the plant into a fast-acting and easily dosed drug and how it later became linked with global capitalism and the slave trade. People often used cannabis to cope with oppressive working conditions under colonialism, as a recreational drug, and in religious and political movements. This expansive look at Africa's importance to the development of human knowledge about marijuana will challenge everything readers thought they knew about one of the world's most ubiquitous plants.

Nigerian drug lords in UK prisons, khat-chewing Somali pirates hijacking Western ships, crystal meth-smoking gangs controlling South Africa's streets, and narco-traffickers corrupting the state in Guinea-Bissau: these are some of the vivid images surrounding drugs in Africa which have alarmed policymakers, academics and the general public in recent years. In this revealing and original book, the authors weave these aspects into a provocative argument about Africa's role in the global trade and control of drugs. In doing so, they show how foreign-inspired policies have failed to help African drug users but have strengthened the role of corrupt and brutal law enforcement officers, who are tasked with halting the export of heroin and cocaine to European and American consumer markets. A vital book on an overlooked front of the so-called war on drugs.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

This volume analyses the prospects and challenges of the African Court of Justice and Human and Peoples' Rights in context. The book is for all readers interested in African institutions and contemporary global challenges of peace, security, human rights, and international law. This title is also available as Open Access on Cambridge Core.